Literature DB >> 33622920

Left Hepatectomy Through Double Approach and Total Vascular Exclusion for Giant Left Lobe Hepatocarcinoma.

Nicolae Bacalbasa1,2, Irina Balescu3, Simona Dima2, Lucian Alecu4, Irinel Popescu5,6.   

Abstract

BACKGROUND/AIM: Hepatocellular carcinoma represents the most frequently encountered liver malignancy worldwide; however the dimensions of these lesions rarely surpass 20 cm. In such cases surgical treatment might encounter significant technical difficulties. CASE REPORT: We present the case of a 49-year-old patient diagnosed with a 22/25/21 cm left lobe hepatocellular carcinoma.
RESULTS: In order to achieve a safe and effective resection total vascular exclusion was needed. Moreover, due to the anatomical relationship between the tumor and the cava vein, an intrathoracic approach of the inferior cava vein was the option of choice. The time of total vascular exclusion was of 26 minutes while the length of surgery was of 210 minutes; meanwhile the estimated blood loss was of 650 ml, while the postoperative outcome was uncomplicated.
CONCLUSION: Total vascular exclusion by double approach might be a safe alternative in order to minimize the risks of severe intraoperative and postoperative complications. Copyright
© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Hepatocellular carcinoma; liver tumor; resection; vascular exclusion

Year:  2021        PMID: 33622920      PMCID: PMC8045090          DOI: 10.21873/invivo.12368

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  30 in total

1.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.

Authors:  J Bruix; M Sherman; J M Llovet; M Beaugrand; R Lencioni; A K Burroughs; E Christensen; L Pagliaro; M Colombo; J Rodés
Journal:  J Hepatol       Date:  2001-09       Impact factor: 25.083

2.  Technique of hepatic vascular exclusion for extensive liver resection.

Authors:  C Huguet; P Addario-Chieco; A Gavelli; E Arrigo; J Harb; R R Clement
Journal:  Am J Surg       Date:  1992-06       Impact factor: 2.565

3.  Splenic artery used for replaced common hepatic artery reconstruction during pancreatoduodenectomy--a case report.

Authors:  V Braşoveanu; T Dumitraşcu; N Bacalbaşa; R Zamfir
Journal:  Chirurgia (Bucur)       Date:  2009 Jul-Aug

4.  Portal triad clamping or hepatic vascular exclusion for major liver resection. A controlled study.

Authors:  J Belghiti; R Noun; E Zante; T Ballet; A Sauvanet
Journal:  Ann Surg       Date:  1996-08       Impact factor: 12.969

Review 5.  The role of hypoxia-induced factors in tumor progression.

Authors:  Peter Vaupel
Journal:  Oncologist       Date:  2004

6.  Resection of a giant hepatocellular carcinoma weighing over ten kilograms.

Authors:  Ming-Chen Ba; Shu-Zhong Cui; Sheng-Qu Lin; Yun-Qiang Tang; Yin-Bing Wu; Xiang-Liang Zhang
Journal:  World J Gastroenterol       Date:  2010-03-21       Impact factor: 5.742

7.  Does vascular occlusion in liver resections predispose to recurrence of malignancy in the liver remnant due to ischemia/reperfusion injury? A comparative retrospective cohort study.

Authors:  Kassiani Theodoraki; Maria Papadoliopoulou; Zoe Petropoulou; Theodosios Theodosopoulos; Pantelis Vassiliu; Andreas Polydorou; Pantelis Xanthakos; George Fragulidis; Vassilios Smyrniotis; Nikolaos Arkadopoulos
Journal:  Int J Surg       Date:  2020-06-30       Impact factor: 6.071

Review 8.  Vascular occlusion techniques during liver resection.

Authors:  Thomas M van Gulik; Wilmar de Graaf; Sander Dinant; Olivier R C Busch; Dirk J Gouma
Journal:  Dig Surg       Date:  2007-07-27       Impact factor: 2.588

9.  Ischemia-reperfusion of small liver remnant promotes liver tumor growth and metastases--activation of cell invasion and migration pathways.

Authors:  Kwan Man; Kevin T Ng; Chung Mau Lo; Joanna W Ho; Bai Shun Sun; Chris K Sun; Terence K Lee; Ronnie T P Poon; Sheung Tat Fan
Journal:  Liver Transpl       Date:  2007-12       Impact factor: 5.799

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.